- Home
- ERNA vs HBIO Comparison
ERNA vs HBIO Comparison
Compare ERNA & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERNA
- HBIO
- Stock Information
- Founded
- ERNA 2018
- HBIO 1901
- Country
- ERNA United States
- HBIO United States
- Employees
- ERNA N/A
- HBIO N/A
- Industry
- ERNA Biotechnology: Pharmaceutical Preparations
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- ERNA Health Care
- HBIO Industrials
- Exchange
- ERNA Nasdaq
- HBIO Nasdaq
- Market Cap
- ERNA 14.2M
- HBIO 15.3M
- IPO Year
- ERNA N/A
- HBIO 2000
- Fundamental
- Price
- ERNA $0.18
- HBIO $0.41
- Analyst Decision
- ERNA
- HBIO Buy
- Analyst Count
- ERNA 0
- HBIO 2
- Target Price
- ERNA N/A
- HBIO $3.00
- AVG Volume (30 Days)
- ERNA 429.2K
- HBIO 34.7M
- Earning Date
- ERNA 06-13-2025
- HBIO 05-12-2025
- Dividend Yield
- ERNA N/A
- HBIO N/A
- EPS Growth
- ERNA N/A
- HBIO N/A
- EPS
- ERNA N/A
- HBIO N/A
- Revenue
- ERNA $535,000.00
- HBIO $91,397,000.00
- Revenue This Year
- ERNA N/A
- HBIO N/A
- Revenue Next Year
- ERNA N/A
- HBIO $9.75
- P/E Ratio
- ERNA N/A
- HBIO N/A
- Revenue Growth
- ERNA 365.22
- HBIO N/A
- 52 Week Low
- ERNA $0.15
- HBIO $0.28
- 52 Week High
- ERNA $2.63
- HBIO $3.60
- Technical
- Relative Strength Index (RSI)
- ERNA 35.43
- HBIO 50.77
- Support Level
- ERNA $0.16
- HBIO $0.28
- Resistance Level
- ERNA $0.25
- HBIO $0.95
- Average True Range (ATR)
- ERNA 0.03
- HBIO 0.10
- MACD
- ERNA -0.01
- HBIO 0.02
- Stochastic Oscillator
- ERNA 22.22
- HBIO 19.45
About ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.